Trade receivables increased 115.8%
Trade receivables changed +115.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$2.3M→$5.0M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →SRZN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy decreased 21.3%
Free-cash-flow proxy changed -21.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
-$6.1M→-$7.4M4 prior comparisons
Operating cash flow decreased 21.3%
Operating cash flow changed -21.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
-$6.1M→-$7.4M4 prior comparisons
Research & development increased 40.4%
Research & development changed +40.4% from the comparable as-filed period.
$6.0M→$8.5M3 prior comparisons
Shares outstanding increased 37.1%
Shares outstanding changed +37.1% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
8,570,355→11,753,5588 prior comparisons
Current assets increased 16.1%
Current assets changed +16.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$94.2M→$109.4M4 prior comparisons
Current ratio decreased 26.0%
Current ratio changed -26.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
16.41→12.144 prior comparisons
Operating income decreased 15.0%
Operating income changed -15.0% from the comparable as-filed period.
-$9.0M→-$10.4M3 prior comparisons
Working capital increased 13.4%
Working capital changed +13.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$88.5M→$100.4M4 prior comparisons
Total assets increased 12.6%
Total assets changed +12.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$102.7M→$115.6M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.